None listed
Conditions
Interventions
Intervention1: Spot corrector serum applied with Ligthinderm device: Treatment will be done once per day in the evening for 3 minutes on clean and dry skin with the device + serum (programme SPOT CORR
Sponsors
Lightinderm
Eligibility
Inclusion criteria
Inclusion criteria: 1. Female adult subjects in general good health as determined from a recent medical history, general physical examination, dermatological assessment. 2. Subjects in the age group of 18-50 years (both ages inclusive). 3. Subjects with various skin types, including normal, dry, oily, and combination, while excluding those with sensitive skin. 4. Subjects with skin phototype III to VI 5. Subjects presenting with uneven skin tone and hyperpigmented spots on the face with a subset of 10 subjects with melasma 6. Subjects free of excessive hair, acne, cuts, abrasions, fissures, wounds, lacerations, or any other active skin conditions on the face as determined by the dermatologist. 7. Subject who agrees not to use any other product/treatment/home remedy/ except the provided product on their face during the study period other than the test and additional products of the study. 8. Subjects who agree not to carry out bleaching or any other procedures including facial etc. on face during the study period. 9. Subjects who agree not to expose to excessive sun light (sun exposure not more than half an hour daily and during that time use of umbrella to cover face). 10. Subjects willing to give a voluntary written informed consent, photography release and agree to come for regular follow-up. 11. Subjects willing to abide by and comply with the study protocol.
Exclusion criteria
Exclusion criteria: 1. Subject with any other signs of significant local irritation or skin disease. 2. Subject currently taking any medication, which the Investigator believes may influence the interpretation of the data. 3. Subject having clinically significant systemic or cutaneous disease, chronic illness or had major surgery in the last year. 4. Subjects who do not agree to remove all jewellery on/around face (e.g., necklace, earrings, if possible nose ring), during VISIA CR imaging. 5. Subjects having hair style which covers almost the entire forehead 6. Subjects undergoing any treatment of any skin condition on their face 7. Subjects not willing to discontinue other topical facial products. 8. Subject allergic or sensitive to bar, cleansing products, cosmetics, creams/lotions, artificial jewellery or anything else. 9. Subjects who are pregnant and lactating 10. Subjects on any medical treatment either systemic/topical in the past 1 month or currently taking medication including food supplements. 11. Subjects with skin allergy, history of atopic dermatitis or psoriasis 12. Subjects who have participated in any other clinical trial in the last 3 months. 13. Subjects who have undergone treatment with Botox/filler /bio stimulatory molecules injection in the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate & compare the efficacy of the Lightinderm device augmented spot corrector serum in providing a reduction in the visibility of spots (intensity) & hyperpigmentation while enhancing the skin luminosity and improving skin tone evenness as per dermatological assessments and non-invasive instruments (Spectrophotometer, VISIA CR, Antera) in 8 weeks when compared to the baseline.Timepoint: T0, Week 1, Week 4, Week 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate improvement in skin clarity, skin texture (exploratory) 2. To evaluate efficacy, safety & skin tolerance of test products in a long-term use for 8 weeks by dermatological evaluation and subjective feedbackTimepoint: T0, Week 1, Week 4, Week 8 | — |
Countries
India
Contacts
Public ContactDr Mukta Sachdev
MS Clinical Research Pvt Ltd
Outcome results
None listed